Data for Lipidomics in high-risk subjects for the identification of integrated biomarker signatures of type 1 diabetes (Study ST001642)
(Analysis AN002687)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 |
|---|---|---|---|---|
| Cer(d18:0+pO/34:1) | 0.6162 | 2.2666 | 0.0591 | 0.1754 |
| dMePE(16:0p/20:4) | 1.0913 | 0.7942 | 1.0783 | 1.1739 |
| LPC(16:0) | 0.8546 | 1.1549 | 1.0725 | 1.0446 |
| LPC(18:1) | 0.7809 | 1.2684 | 1.0684 | 1.0028 |
| LPC(18:2) | 1.0820 | 0.8298 | 1.4602 | 0.8043 |
| PC(16:0/16:0) | 1.0807 | 0.9381 | 0.9258 | 0.9369 |
| PC(16:0/16:1) | 1.2991 | 0.7431 | 0.8418 | 0.7327 |
| PC(16:0/18:1) | 1.0518 | 0.8925 | 1.0814 | 1.0340 |
| PC(16:0/18:2) | 1.0250 | 0.9138 | 1.1169 | 1.0415 |
| PC(16:0/20:3) | 0.8898 | 1.0977 | 1.2271 | 0.9203 |
| PC(16:0/20:4) | 1.1608 | 0.5961 | 1.2888 | 1.2795 |
| PC(16:0/22:5) | 1.1029 | 0.6908 | 1.2749 | 1.2412 |
| PC(16:0/22:6) | 1.1473 | 0.5472 | 1.3846 | 1.3846 |
| PC(16:0e/20:4) | 0.9937 | 0.8864 | 1.2074 | 1.1586 |
| PC(16:0p/20:4) | 0.8474 | 0.8329 | 1.6450 | 1.4669 |
| PC(18:0/18:1) | 1.0114 | 0.9413 | 1.1009 | 1.0293 |
| PC(18:0/18:2) | 0.9487 | 1.0702 | 0.9848 | 1.0099 |
| PC(18:0/20:3) | 0.9474 | 0.9487 | 1.2417 | 1.1225 |
| PC(18:0/20:4) | 1.0343 | 0.6580 | 1.5146 | 1.3744 |
| PC(18:0/22:6) | 1.0700 | 0.5926 | 1.4919 | 1.4502 |
| PC(18:0p/20:4) | 0.9539 | 0.8706 | 1.4412 | 1.1312 |
| PC(18:1/20:4) | 0.9458 | 0.7561 | 1.4937 | 1.4547 |
| PC(18:2/18:2) | 0.8426 | 1.2394 | 1.0701 | 0.8411 |
| PC(32:0) | 1.1282 | 0.8392 | 0.8793 | 1.0903 |
| PC(32:1) | 1.3255 | 0.7139 | 0.7638 | 0.7924 |
| PC(34:1) | 1.0939 | 0.8281 | 1.0594 | 1.0806 |
| PC(34:2) | 1.0650 | 0.8633 | 1.0890 | 1.0608 |
| PC(36:1) | 0.9754 | 0.9351 | 1.1178 | 1.1755 |
| PC(36:2) | 1.0606 | 0.8318 | 1.2283 | 1.0338 |
| PC(36:3) | 1.0562 | 0.9241 | 0.9650 | 1.0379 |
| PC(36:4) | 1.1662 | 0.6155 | 1.2061 | 1.2824 |
| PC(38:3) | 1.0849 | 0.9099 | 0.9517 | 0.9788 |
| PC(38:4) | 1.0290 | 0.6256 | 1.4784 | 1.5288 |
| PC(38:5) | 1.0324 | 0.6894 | 1.3536 | 1.4484 |
| PC(38:6) | 1.1885 | 0.4925 | 1.3478 | 1.4210 |
| PC(40:6) | 1.1481 | 0.4476 | 1.4383 | 1.6263 |
| PE(16:0p/20:4) | 1.1198 | 0.7964 | 1.0740 | 1.0579 |
| PE(18:0/18:2) | 1.3481 | 0.5549 | 0.8642 | 1.0786 |
| PE(18:0/20:4) | 1.3445 | 0.5611 | 0.8053 | 1.1334 |
| PE(18:0p/20:4) | 1.1087 | 0.7998 | 1.0395 | 1.1262 |
| PE(38:5p) | 1.0656 | 0.7860 | 1.3032 | 1.0764 |
| PI(18:0/20:4) | 1.0085 | 0.8755 | 1.2155 | 1.1241 |
| PS(18:0/20:4) | 1.2501 | 0.8124 | 0.4469 | 1.1157 |
| PS(37:1) | 1.0231 | 0.9146 | 1.1197 | 1.0439 |
| PS(39:1) | 1.2363 | 0.7482 | 0.8937 | 0.9165 |
| PS(39:2) | 0.9030 | 1.0717 | 1.1740 | 0.9987 |
| PS(39:3) | 1.1035 | 0.6880 | 1.2861 | 1.2361 |
| SM(d15:0/21:1) | 1.0306 | 0.8478 | 1.2260 | 1.1083 |
| SM(d22:0/18:1) | 1.0614 | 0.6918 | 1.3496 | 1.3296 |
| SM(d22:0/20:3) | 1.0203 | 0.7071 | 1.4581 | 1.3394 |
| SM(d22:1/18:1) | 1.0702 | 0.7589 | 1.2368 | 1.2055 |
| SM(d34:1) | 1.0349 | 0.8046 | 1.2267 | 1.2201 |
| SM(d40:1) | 1.0852 | 0.6747 | 1.3708 | 1.2642 |
| SM(d41:1) | 1.0141 | 0.8141 | 1.4100 | 1.0911 |
| SM(d42:1) | 1.0065 | 0.6594 | 1.5962 | 1.3995 |
| SM(d42:2) | 1.0783 | 0.7022 | 1.2867 | 1.2933 |
| SM(d42:3) | 1.0554 | 0.7341 | 1.2826 | 1.2935 |
Factors:
| F1 | Disease status:Control |
| F2 | Disease status:HRT1D |
| F3 | Disease status:NOF |
| F4 | Disease status:NOPP |
